Tg Therapeutics (TGTX) Other Operating Expenses (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Other Operating Expenses of $38.4 million for Q1 2026, up 146.99% year-over-year from $15.5 million in Q1 2025, and up 0.64% quarter-over-quarter from $38.1 million in Q4 2025.
Tg Therapeutics (TGTX) Other Operating Expenses (2011 - 2026) Analysis & Trends
Tg Therapeutics' Other Operating Expenses history runs 16 years deep, the most recent figure standing at $38.4 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 146.99% year-over-year to $38.4 million; the TTM figure through Mar 2026 stood at $128.9 million (up 149.09% YoY), while the FY2025 annual figure was $100.7 million, up 102.86% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $38.4 million, up from $38.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $38.4 million in Q1 2026, with the low at $2000.0 in Q3 2022.
- The 5-year median for Other Operating Expenses is $8.3 million (2024), against an average of $12.7 million.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 99.96% in 2022, then surged 321100.0% in 2023.
- Tg Therapeutics' Other Operating Expenses stood at $13.2 million in 2022, then tumbled by 40.62% to $7.9 million in 2023, then surged by 136.3% to $18.6 million in 2024, then soared by 105.52% to $38.1 million in 2025, then advanced by 0.64% to $38.4 million in 2026.
- Business Quant data shows TGTX's Other Operating Expenses at $38.4 million in Q1 2026, $38.1 million in Q4 2025, and $33.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.19 Mn |
| Mar 31, 2026 | 38.39 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Sep 30, 2025 | 33.43 Mn |
| Jun 30, 2025 | 18.94 Mn |
| Mar 31, 2025 | 15.54 Mn |
| Dec 31, 2024 | 18.56 Mn |
| Sep 30, 2024 | 9.34 Mn |
| Jun 30, 2024 | 8.30 Mn |
| Mar 31, 2024 | 5.44 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Sep 30, 2023 | 6.42 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 857,000.00 |
| Dec 31, 2022 | 13.23 Mn |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Dec 31, 2021 | 5.20 Mn |
| Sep 30, 2021 | 4.83 Mn |